⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for reparixin

Every month we try and update this database with for reparixin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast CancerNCT05212701
Fatigue
Locally Advance...
Reparixin
Placebo
18 Years - Dompé Farmaceutici S.p.A
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)NCT05835466
Myelofibrosis (...
Post Essential ...
Post Polycythem...
reparixin
18 Years - Icahn School of Medicine at Mount Sinai
A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast CancerNCT02370238
Metastatic Brea...
paclitaxel
Reparixin
placebo
18 Years - Dompé Farmaceutici S.p.A
A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast CancerNCT02370238
Metastatic Brea...
paclitaxel
Reparixin
placebo
18 Years - Dompé Farmaceutici S.p.A
To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast CancerNCT05212701
Fatigue
Locally Advance...
Reparixin
Placebo
18 Years - Dompé Farmaceutici S.p.A
To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast CancerNCT05212701
Fatigue
Locally Advance...
Reparixin
Placebo
18 Years - Dompé Farmaceutici S.p.A
A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast CancerNCT02370238
Metastatic Brea...
paclitaxel
Reparixin
placebo
18 Years - Dompé Farmaceutici S.p.A
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: